Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoints Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biotyping placebo and treatment-specific responses for precision medicine
Lupus Glomenulonephritis and NK T cells
Elucidating structure-function relationships of lipid A: A synthetic approach
Ultrafast Time-Resolved Crystallography on Scapharca Hb
Mechanical Control and Energetics of Muscle Contraction
Recently added grants:
Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway
Mechanism of Intratumoral Transport of Particulate Drugs
Novel bioengineered microRNA therapeutics for lung cancer
The Study of Immune Effects in Gliomas Treated with Oncolytic Viruses in Combination with IDO Inhibitors
Molecular Mechanisms of Castration Resistant Prostate Cancer Recurrence & Therapeutic Strategies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43308-6-0-1
Application #
7587174
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/ Washington University
$1,406,468
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
You, Ming /
$1,882,921
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
Comments
Be the first to comment on this grant